First-line initial immunosuppression for pure MLN. Values are n (%).
| Variables | Steroids | MMF | CNI | CYC | RTX | AZA | None |
|---|---|---|---|---|---|---|---|
| MLN with NS | |||||||
| Pediatric rheumatologists, n = 57 | 56 (98) | 44 (77) | 15 (26) | 4 (7) | 4 (7) | 1 (2) | 1 (2) |
| Pediatric nephrologists, n = 60 | 55 (91) | 30 (50) | 9 (15) | 9 (15) | 6 (10) | 1 (2) | 10 (17) |
| MLN without NS | |||||||
| Pediatric rheumatologists, n = 52 | 52 (93) | 39 (75) | 10 (19) | 2 (4) | 1 (2) | 2 (4) | 7 (13) |
| Pediatric nephrologists, n = 55 | 34 (60) | 21 (38) | 5 (9) | 2 (4) | 3 (5) | 1 (2) | 26 (47) |
MLN: membranous lupus nephritis; NS: nephrotic syndrome; MMF: mycophenolate; CNI: calcineurin inhibitors; CYC: cyclophosphamide; RTX: rituximab; AZA: azathioprine.